Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orally.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples